SPY314.38-1.80 -0.57%
DIA257.24-3.48 -1.33%
IXIC10,547.75+55.25 0.53%

Moleculin Biotech shares are trading higher after the company reported its preclinical data confirmed the efficacy in lung metastases.

Benzinga · -